Advertisement

Topics

Innovative Biologics, Inc. Company Profile

14:21 EDT 19th June 2018 | BioPortfolio

Innovative Biologics was established in December, 2003 and its research is supported by the NIH SBIR Phase II grant “Small molecule blockers of B. anthracis toxin.” Our company is located on the Prince Williams campus of George Mason University.
Our focus is to search for new anti-microbial drugs targeting bacterial toxins.

Location

10900 University BlvdMSN 1A8, Discovery Hall, Room 160
Manassas
Virginia
20110
United States of America

Contact

Phone: (703) 993-8544
Fax: (703) 993-8982
Email: info@innovbio.com


News Articles [588 Associated News Articles listed on BioPortfolio]

WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United ...

WuXi Biologics is a leading global platform company providing end-to-end solutions for biologics with a mission to accelerate and transform biologics discovery, development and manufacturing Read ...

Covance forms I&I unit to meet increasing demand for biologics services

Covance has formed a global immunology and immunotoxicology (I&I) unit, which will be dedicated to the âinnovative and complexâ approaches required by biologics, says CRO.

GenSight Biologics Reports €55 Million 2017 Year-End Cash Position and Provides Corporate Update

Regulatory News: GenSight Biologics (Paris: SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for ...

WuXi Biologics To Be ‘World’s No.1’ Biologics Maker

WuXi Biologics is aiming high to become the world’s biggest biologics manufacturer within five years after seeing strong confidence from...   

CFDA proposes 12-year data exclusivity for innovative biologics

#jobs #lifescience QA Specialist, Biologics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: QA Specialist, Biologics .NJ-Princeton, Reporting to the QA Director or Biolo...

AGC Biologics Cleared for Commercial Manufacture of Portola's FDA-Approved Andexxa

Drug Substance produced in AGC Biologics' facility in Bothell, Washington BOTHELL, Washington, May 24, 2018 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing ...

WuXi Biologics to establish $60m biologics manufacturing facility in Singapore

Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore.

PubMed Articles [330 Associated PubMed Articles listed on BioPortfolio]

Biologics for pityriasis rubra pilaris treatment: a review of the literature.

Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous skin disease, often refractory to conventional therapies. The off-label use of biologics, such as anti-TNF, -IL-12/IL-23, -IL-17 ag...

Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma.

Biologics containing growth factors are frequently used to enhance healing after musculoskeletal injuries. One mechanism of action is thought to be though the ability of biologics to induce homing and...

Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naïve patients from the French national health insurance database (SNIIRAM).

Long-term clinical effectiveness of biologics in psoriasis is needed.

Biologics Monitoring: Incongruity between Recommendations and Clinician Monitoring Trends.

Biologics are a commonly used treatment for moderate to severe psoriasis. Monitoring laboratory test overuse provide little definitive benefit to patients.

Using insurance claims to predict and improve hospitalizations and biologics use in members with inflammatory bowel diseases.

Inflammatory Bowel Disease (IBD) is an inflammatory disorder of the gastrointestinal tract that can necessitate hospitalization and the use of expensive biologics. Models predicting these intervention...

Clinical Trials [666 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Companies [497 Associated Companies listed on BioPortfolio]

Innovative Biologics, Inc.

Innovative Biologics was established in December, 2003 and its research is supported by the NIH SBIR Phase II grant “Small molecule blockers of B. anthracis toxin.” Our company is located on the ...

GT Biologics

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases. GT Biologics aim to deliver a new class of medicine based on the po...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

Precision Biologics Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

More Information about "Innovative Biologics, Inc." on BioPortfolio

We have published hundreds of Innovative Biologics, Inc. news stories on BioPortfolio along with dozens of Innovative Biologics, Inc. Clinical Trials and PubMed Articles about Innovative Biologics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innovative Biologics, Inc. Companies in our database. You can also find out about relevant Innovative Biologics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record